May 11, 2020 / 11:04 PM / a month ago

BRIEF-Cara Therapeutics Reports Q1 Loss Per Share $0.62

May 11 (Reuters) - Cara Therapeutics Inc:

* CARA THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 REVENUE ESTIMATE $4.8 MILLION — REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE ESTIMATE $-0.62 — REFINITIV IBES DATA

* CARA THERAPEUTICS - EXPECTS EXISTING CASH, CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND ITS ANTICIPATED OPERATING EXPENSES & CAP EX INTO SECOND HALF OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below